Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-01-06
2010-11-16
Cheu, Jacob (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200
Reexamination Certificate
active
07833725
ABSTRACT:
The invention involves assays, diagnostics, kits, and assay components for mass spectrometry and other methods to determine levels of glycated CD59 in subjects.
REFERENCES:
patent: 4281061 (1981-07-01), Zuk et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5225539 (1993-07-01), Winter
patent: 5470759 (1995-11-01), Sugiyama et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5789208 (1998-08-01), Sharon
patent: 5853703 (1998-12-01), Cerami et al.
patent: 5859205 (1999-01-01), Adair et al.
patent: 6835545 (2004-12-01), Halperin
patent: 7049082 (2006-05-01), Halperin
patent: 7439330 (2008-10-01), Halperin
patent: 2004/0119010 (2004-06-01), Perryman et al.
patent: 2004/0219606 (2004-11-01), Halperin
patent: 2005/0032128 (2005-02-01), Halperin
patent: 2006/0257936 (2006-11-01), Halperin
patent: 2009/0191574 (2009-07-01), Halperin
patent: 0394035 (1990-10-01), None
patent: 1789449 (2007-05-01), None
patent: WO 98/19711 (1998-05-01), None
patent: WO 2004/106941 (2004-12-01), None
patent: WO 2006/009533 (2006-01-01), None
patent: WO 2006/086098 (2006-08-01), None
Ninomiya et al. (J Biol. Chem. 1992, vol. 267, p. 8404-8410).
Acosta et al., Complement and complement regulatory proteins as potential molecular targets for vascular diseases. Current Pharmaceutical Design, 2004;10:1-9.
Acosta et al., Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A. May 9, 2000;97(10):5450-5.
Benzaquen et al., Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med. Mar. 1, 1994;179(3):985-92.
Bodian et al., Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J Exp Med. Feb. 3, 1997;185(3):507-16.
Davies et al., CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med. Sep. 1, 1989;170(3):637-54.
Fletcher et al., Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. Structure. Mar. 15, 1994;2(3):185-99.
Halperin et al, Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9). Blood. Jan. 1, 1993;81(1):200-5.
Halperin et al., Properties of the Na+-K+ pump in human red cells with increased number of pump sites. J Clin Invest. Jul. 1987;80(1):128-37.
Halperin et al., Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. J Clin Invest. May 1993;91(5):1974-8.
Harlow et al., Antibodies: A Laboratory Manual. 1998;321-323.
Hughes et al., Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J. May 15, 1992;284 ( Pt 1):169-76.
Lapolla et al., The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes. Mass Spectrom Rev. Sep.-Oct. 2000;19(5):279-304. Review.
Myint, et al., Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG. Biochim Biophys Acta. Oct. 17, 1995;1272(2):73-9.
Philbrick et al., The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility. Eur J Immunol. Jan. 1990;20(1):87-92.
Qin et al., Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b. Mamm Genome. Aug. 2001;12(8):582-9.
Qin et al., A role of glycated human CD59 and the complement system in the pathogenesis of chronic vascular complications of diabetes. Elsevier. Aug. 2002;2(9):1382-3.
Rosoklija et al., Local activation of the complement system in endoneurial microvessels of diabetic neuropathy. Acta Neuropathol. Jan. 2000;99(1):55-62.
Suzuki et al., Immunofluorescence staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus using monoclonal antibody to reduced glycated lysine. J Diabetes Complications. Nov.-Dec. 1996;10(6):314-9.
Takata et al., Glycated Cu,Zn-superoxide dismutase in rat lenses: evidence for the presence of fragmentation in vivo. Biochem Biophys Res Commun. Feb. 6, 1996;219(1):243-8.
Van Den Berg et al., The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity. Immunology. Mar. 1993;78(3):349-57.
Zhang et al., Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes. Dec. 2002;51(12):3499-504.
Zhao, et al., Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement. J. Biol. Chem. 266: 13418-13422, 1991.
International Preliminary Report on Patentability mailed Nov. 19, 2009 in connection with application No. PCT/US2008/005831.
International Search Report mailed Aug. 27, 2008 in connection with application No. PCT/US2008/005831.
Office Action mailed Feb. 27, 2006 for U.S. Appl. No. 10/870,342.
Walton et al., Synthesis of N-(1-deoxyhexito1-1-yl)amino acids, reference compounds for the nonenzymic glycosylation of proteins. Carbohydr Res. May 15, 1984;128(1):37-49.
Baker C. Hunter
Cheu Jacob
President and Fellows of Harvard College
Wolf Greenfield & Sacks P.C.
LandOfFree
Mass spectrometric methods and products does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mass spectrometric methods and products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mass spectrometric methods and products will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4251415